Lipid Standards

Library of Glycerophospholipids Standards

Clicking on a LM_ID displays the structure in GIF (or Chemdraw) format.
Clicking on a MS/MS value (nominal mass of precursor ion) displays the fragmentation spectrum, including structures of principal product ions.
Clicking on a AVANTI_ID value displays the Avanti catalog website page.
Clicking on a Ref value displays a literature reference(s) pertaining to identification of fragment structures.
View LC/MS/MS protocols and retention-time data
Lipid Search: Name: e.g. PA(12:0/12:0)
LM_IDnameSystematic_NameAvanti_ID MS/MS Ion Conditions
LMGP01010407 PC(11:0/11:0) 1,2-diundecanoyl-sn-glycero-3-phosphocholine - 594([M+H]+) [M+H]+ Details
LMGP01010407 PC(11:0/11:0) 1,2-diundecanoyl-sn-glycero-3-phosphocholine - 628([M.Cl]-) [M.Cl]- Details
LMGP01010429 PC(12:0/12:0) 1,2-didodecanoyl-sn-glycero-3-phosphocholine - 622([M+H]+) [M+H]+ Details
LMGP01010429 PC(12:0/12:0) 1,2-didodecanoyl-sn-glycero-3-phosphocholine - 656([M.Cl]-) [M.Cl]- Details
LMGP01010001 PC(12:0/13:0) 1-dodecanoyl-2-tridecanoyl-sn-glycero-3-
phosphocholine
LMGP01010001 636([M+H]+) [M+H]+ Details
LMGP01010001 PC(12:0/13:0) 1-dodecanoyl-2-tridecanoyl-sn-glycero-3-
phosphocholine
LMGP01010001 670([M.Cl]-) [M.Cl]- Details
LMGP01010477 PC(14:0/14:0) 1,2-ditetradecanoyl-sn-glycero-3-phosphocholine - 678([M+H]+) [M+H]+ Details
LMGP01010477 PC(14:0/14:0) 1,2-ditetradecanoyl-sn-glycero-3-phosphocholine - 712([M.Cl]-) [M.Cl]- Details
LMGP01010523 PC(14:1(9Z)/14:1(9Z)) 1,2-di-(9Z-tetradecenoyl)-sn-glycero-3-
phosphocholine
- 674([M+H]+) [M+H]+ Details
LMGP01010523 PC(14:1(9Z)/14:1(9Z)) 1,2-di-(9Z-tetradecenoyl)-sn-glycero-3-
phosphocholine
- 708([M.Cl]-) [M.Cl]- Details
LMGP01010002 PC(16:0/15:1(14)) 1-hexadecanoyl-2-(14-pentadecenoyl)-sn-glycero-3-
phosphocholine
- 718([M+H]+) [M+H]+ Details
LMGP01010002 PC(16:0/15:1(14)) 1-hexadecanoyl-2-(14-pentadecenoyl)-sn-glycero-3-
phosphocholine
- 752([M.Cl]-) [M.Cl]- Details
LMGP01010564 PC(16:0/16:0) 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine - 734([M+H]+) [M+H]+ Details
LMGP01010564 PC(16:0/16:0) 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine - 768([M.Cl]-) [M.Cl]- Details
LMGP01010005 PC(16:0/18:1(9Z)) 1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-
phosphocholine
- 760([M+H]+) [M+H]+ Details
LMGP01010005 PC(16:0/18:1(9Z)) 1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-
phosphocholine
- 794([M.Cl]-) [M.Cl]- Details
LMGP01010007 PC(16:0/20:4(5Z,8Z,11Z,14Z)) 1-hexadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)
-sn-glycero-3-phosphocholine
- 766([M-CH3]-) [M-CH3]- Details
LMGP01010007 PC(16:0/20:4(5Z,8Z,11Z,14Z)) 1-hexadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)
-sn-glycero-3-phosphocholine
- 782([M+H]+) [M+H]+ Details
LMGP01010008 PC(17:0/14:1(9Z)) 1-heptadecanoyl-2-(9Z-tetradecenoyl)-sn-glycero-
3-phosphocholine
LMGP01010008 718([M+H]+) [M+H]+ Details
LMGP01010008 PC(17:0/14:1(9Z)) 1-heptadecanoyl-2-(9Z-tetradecenoyl)-sn-glycero-
3-phosphocholine
LMGP01010008 752([M.Cl]-) [M.Cl]- Details
LMGP01010707 PC(17:0/17:0) 1,2-diheptadecanoyl-sn-glycero-3-phosphocholine - 762([M+H]+) [M+H]+ Details
LMGP01010707 PC(17:0/17:0) 1,2-diheptadecanoyl-sn-glycero-3-phosphocholine - 796([M.Cl]-) [M.Cl]- Details
LMGP01010003 PC(17:0/20:4(5Z,8Z,11Z,14Z)) 1-heptadecanoyl-2-(5Z,8Z,11Z,14Z-
eicosatetraenoyl)-sn-glycero-3-phosphocholine
LMGP01010003 796([M+H]+) [M+H]+ Details
LMGP01010003 PC(17:0/20:4(5Z,8Z,11Z,14Z)) 1-heptadecanoyl-2-(5Z,8Z,11Z,14Z-
eicosatetraenoyl)-sn-glycero-3-phosphocholine
LMGP01010003 830([M.Cl]-) [M.Cl]- Details
LMGP01010802 PC(18:0/20:4(5Z,8Z,11Z,14Z)) 1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)
-sn-glycero-3-phosphocholine
- 810([M+H]+) [M+H]+ Details
LMGP01010802 PC(18:0/20:4(5Z,8Z,11Z,14Z)) 1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)
-sn-glycero-3-phosphocholine
- 844([M.Cl]-) [M.Cl]- Details
LMGP01010821 PC(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 1-octadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-
docosahexaenoyl)-sn-glycero-3-phosphocholine
- 834([M+H]+) [M+H]+ Details
LMGP01010821 PC(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 1-octadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-
docosahexaenoyl)-sn-glycero-3-phosphocholine
- 868([M.Cl]-) [M.Cl]- Details
LMGP01010882 PC(18:1(9Z)/14:0) 1-(9Z-octadecenoyl)-2-tetradecanoyl-sn-glycero-3-
phosphocholine
- 766([M.Cl]-) [M.Cl]- Details
LMGP01010890 PC(18:1(9Z)/18:1(9Z)) 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-
phosphocholine
- 786([M+H]+) [M+H]+ Details
LMGP01010890 PC(18:1(9Z)/18:1(9Z)) 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-
phosphocholine
- 820([M.Cl]-) [M.Cl]- Details
LMGP01010956 PC(18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)) 1,2-di-(9Z,12Z,15Z-octadecatrienoyl)-sn-glycero-
3-phosphocholine
- 778([M+H]+) [M+H]+ Details
LMGP01010956 PC(18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)) 1,2-di-(9Z,12Z,15Z-octadecatrienoyl)-sn-glycero-
3-phosphocholine
- 812([M.Cl]-) [M.Cl]- Details
LMGP01011014 PC(20:0/20:0) 1,2-dieicosanoyl-sn-glycero-3-phosphocholine - 814([M+H]+) [M+H]+ Details
LMGP01011014 PC(20:0/20:0) 1,2-dieicosanoyl-sn-glycero-3-phosphocholine - 848([M.Cl]-) [M.Cl]- Details
LMGP01010004 PC(21:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 1-heneicosanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-
docosahexaenoyl)-sn-glycero-3-phosphocholine
LMGP01010004 876([M+H]+) [M+H]+ Details
LMGP01010004 PC(21:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 1-heneicosanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-
docosahexaenoyl)-sn-glycero-3-phosphocholine
LMGP01010004 910([M.Cl]-) [M.Cl]- Details
LMGP01011110 PC(22:1(13Z)/22:1(13Z)) 1,2-di-(13Z-docosenoyl)-sn-glycero-3-
phosphocholine
- 898([M+H]+) [M+H]+ Details
LMGP01011110 PC(22:1(13Z)/22:1(13Z)) 1,2-di-(13Z-docosenoyl)-sn-glycero-3-
phosphocholine
- 932([M.Cl]-) [M.Cl]- Details
LMGP01011222 PC(4:0/4:0) 1,2-dibutyryl-sn-glycero-3-phosphocholine - 398([M+H]+) [M+H]+ Details
LMGP01011222 PC(4:0/4:0) 1,2-dibutyryl-sn-glycero-3-phosphocholine - 432([M.Cl]-) [M.Cl]- Details
LMGP01020003 PC(O-16:0/18:1(9Z)) 1-hexadecyl-2-(9Z-octadecenoyl)-sn-glycero-3-
phosphocholine
- 746([M+H]+) [M+H]+ Details
LMGP01020003 PC(O-16:0/18:1(9Z)) 1-hexadecyl-2-(9Z-octadecenoyl)-sn-glycero-3-
phosphocholine
- 780([M.Cl]-) [M.Cl]- Details
LMGP01020053 PC(O-16:0/20:3(8Z,11Z,14Z)) 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-
glycero-3-phosphocholine
- 770([M+H]+) [M+H]+ Details
LMGP01020053 PC(O-16:0/20:3(8Z,11Z,14Z)) 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-
glycero-3-phosphocholine
- 804([M.Cl]-) [M.Cl]- Details
LMGP01020056 PC(O-16:0/20:4(5Z,8Z,11Z,14Z)) 1-hexadecyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-
sn-glycero-3-phosphocholine
- 768([M+H]+) [M+H]+ Details
LMGP01020056 PC(O-16:0/20:4(5Z,8Z,11Z,14Z)) 1-hexadecyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-
sn-glycero-3-phosphocholine
- 802([M.Cl]-) [M.Cl]- Details
LMGP01020094 PC(O-18:0/2:0) 1-octadecyl-2-acetyl-sn-glycero-3-phosphocholine - 552([M+H]+) [M+H]+ Details
LMGP01020094 PC(O-18:0/2:0) 1-octadecyl-2-acetyl-sn-glycero-3-phosphocholine - 586([M.Cl]-) [M.Cl]- Details
LMGP01030013 PC(P-18:0/18:1(9Z)) 1-(1Z-octadecenyl)-2-(9Z-octadecenoyl)-sn-
glycero-3-phosphocholine
- 772([M+H]+) [M+H]+ Details
logo LIPID MAPS is funded by a Wellcome Trust.